...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
【24h】

Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.

机译:对外源性乙型肝炎表面抗原的初始MHC-1限制性细胞毒性T淋巴细胞应答是CD4 + T细胞依赖性的。

获取原文
获取原文并翻译 | 示例
           

摘要

MHC-I (Ld)-restricted, S28-39-specific CTL responses are efficiently primed in H-2d BALB/c mice injected with low doses of native hepatitis B surface Ag (HBsAg) lipoprotein particles without adjuvants. Priming of this CTL response by exogenous HBsAg required CD4+ T cell "help" and IL-12: this CTL response could be neither induced in mice depleted of CD4+ T cells by in vivo Ab treatment, nor in (CD4+ T cell-competent or CD4+ T cell-depleted) IL-12-unresponsive STAT4-/- knockout BALB/c mice. Codelivery of oligonucleotides (ODN) with immunostimulating CpG sequences (ISS) with exogenous HBsAg reconstituted the CTL response to exogenous HBsAg in CD4+ T cell-depleted normal mice and in CD4+ T cell-competent and CD4+ T cell-depleted STAT4-/- BALB/c mice. Injection (by different routes) of "naked" pCI/S plasmid DNA encoding HBsAg into IL-12-responsive or -unresponsive BALB/c mice efficiently primed the MHC-I-restricted, HBsAg-specific CTL response. CTL priming was not detectable when CD4+ T cell-depleted animals were subjected to genetic immunization. In vivo priming of the well-characterized CD8+ CTL response to HBsAg in "high responder" BALB/c mice either by exogenous surface lipoprotein particles or by DNA vaccination is thus CD4+ T cell dependent. CTL priming by exogenous HBsAg, but not by genetic immunization, is IL-12 dependent. The dependence of CTL priming by exogenous HBsAg on CD4+ T cells can be overcome by codelivering ODN with ISS motifs, and this "adjuvants effect" operates efficiently in IL-12-unresponsive mice. The data characterize a feature of the adjuvant effect of ISS-containing ODN on CTL priming that may be of major interest for the design of CTL-stimulating vaccines with efficacy in immunodeficiency conditions.
机译:MHC-1(Ld)限制的S28-39特异性CTL反应在注射有低剂量天然乙型肝炎表面抗原(HBsAg)脂蛋白颗粒而无佐剂的H-2d BALB / c小鼠中有效引发。通过外源性HBsAg引发这种CTL反应需要CD4 + T细胞“帮助”和IL-12:在体内Ab处理的缺损CD4 + T细胞的小鼠中,或者在(具有CD4 + T细胞能力或CD4 + T细胞耗竭)IL-12无反应的STAT4-/-敲除BALB / c小鼠。带有外源性HBsAg的具有免疫刺激性CpG序列(ISS)的寡核苷酸(ODN)的共传递重构了CD4 + T细胞缺失的正常小鼠以及CD4 + T细胞能力和CD4 + T细胞缺失的STAT4-/-BALB /中对外源HBsAg的CTL反应c只小鼠。 (通过不同途径)将编码HBsAg的“裸” pCI / S质粒DNA注射到IL-12应答或无应答的BALB / c小鼠中,有效地引发了MHC-1限制的HBsAg特异性CTL应答。当耗竭CD4 + T细胞的动物进行基因免疫时,无法检测到CTL启动。因此,通过外源性表面脂蛋白颗粒或DNA疫苗对“高反应性” BALB / c小鼠体内特征明确的CD8 + CTL对HBsAg的引发是CD4 + T细胞依赖性的。通过外源性HBsAg(而非通过基因免疫)引发的CTL依赖IL-12。外源性HBsAg对CD4 + T细胞引发CTL的依赖性可以通过将带有ISS基序的ODN编码为ODN来克服,这种“佐剂效应”在IL-12无反应的小鼠中有效发挥作用。数据表征了含ISS的ODN对CTL启动的佐剂作用特征,这可能是设计在免疫缺陷条件下有效的CTL刺激疫苗的主要兴趣所在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号